Andrew Sachs
Analyst
JMP Securities
Equibles does not estimate personal net worth.
About Andrew Sachs
Andrew Sachs is recorded as Analyst at JMP Securities. Andrew Sachs has spoken on 1 earnings call across 1 company, most recently for Arcutis Biotherapeutics, Inc. on November 4, 2026. The companies whose calls Andrew Sachs spoke on are classified in the Healthcare sector.
Andrew Sachs on recent calls
“Maybe the first one as a follow-up to BD, because, Frank, you said BD isn't nice to have, not a must-have. My question is, what would you do with all the cash you're going to be building up in the next few quarters otherwise?”
Affiliation history
-
JMP Securities
Analyst
Transcript header (unverified)
Current